Display options
Cite
Oh DY, Fong L, Newell EW, et al. Toward a better understanding of T cells in cancer. Cancer Cell. 2021;39(12):1549-1552doi: 10.1016/j.ccell.2021.11.010.
Oh, D. Y., Fong, L., Newell, E. W., Turk, M. J., Chi, H., Chang, H. Y., Satpathy, A. T., Fairfax, B., Silva-Santos, B., & Lantz, O. (2021). Toward a better understanding of T cells in cancer. Cancer cell, 39(12), 1549-1552. https://doi.org/10.1016/j.ccell.2021.11.010
Oh, David Y, et al. "Toward a better understanding of T cells in cancer." Cancer cell vol. 39,12 (2021): 1549-1552. doi: https://doi.org/10.1016/j.ccell.2021.11.010
Oh DY, Fong L, Newell EW, Turk MJ, Chi H, Chang HY, Satpathy AT, Fairfax B, Silva-Santos B, Lantz O. Toward a better understanding of T cells in cancer. Cancer Cell. 2021 Dec 13;39(12):1549-1552. doi: 10.1016/j.ccell.2021.11.010. PMID: 34906313.
Copy Download .nbib Format: NLM
Share it on

Cancer Cell. 2021 Dec 13;39(12):1549-1552. doi: 10.1016/j.ccell.2021.11.010.

Toward a better understanding of T cells in cancer.

Cancer cell

David Y Oh, Lawrence Fong, Evan W Newell, Mary Jo Turk, Hongbo Chi, Howard Y Chang, Ansuman T Satpathy, Benjamin Fairfax, Bruno Silva-Santos, Olivier Lantz

PMID: 34906313 DOI: 10.1016/j.ccell.2021.11.010

Abstract

T cells mediate anti-tumor immune responses and are the key target of immune checkpoint therapy, but they can also promote immune tolerance. A clear understanding of the specific contributions and biology of different T cell subsets is required to fully harness the curative potential of immunotherapies. Experts discuss the state of the field and key challenges for moving forward.

Copyright © 2021 Elsevier Inc. All rights reserved.

Publication Types